Aquilo Partners prides itself on its focused, diligent and collaborative team. Our deals and advisory services span the gamut of inflection points within the life science life cycle, allowing each member of our team to bring a unique perspective to our engagements. We have spent decades developing relationships in the life sciences sector, often advising our clients throughout their careers. On each transaction, we devote a senior team of bankers committed to a transparent, thoughtful approach to success. As further testament to our team’s dedication to our clients, after fifteen years of business, the vast majority of our engagement involve repeat clients or are referral-based from previous successful transactions. For more information on our team’s individual backgrounds, please click on a name to the left.
Bio
Elijah joined Aquilo Partners in September 2023. Elijah received his BS in Human Science in 2023 from Georgetown University, where he also conducted research characterizing the inflammatory profile of Nonalcoholic fatty liver disease under SGLT2 inhibition and was a member of the Men’s Heavyweight Rowing team.
Contact
Phone: (617) 875-0032
BioJohn joined Aquilo Partners in 2009 from JP Morgan, where he was an Executive Director in the healthcare investment banking group. Joining JP Morgan in 2006, John advised public and private biotechnology clients on a wide range of strategic and financing engagements. From 2000 to 2006, John was a member of the healthcare investment banking group at Cowen and Company in New York and San Francisco, where he focused on small and mid-cap public and private biotechnology clients.
His experience includes partnering, sellsides, acquisitions, divestitures, IPOs and follow-on offerings in the biotechnology, specialty pharma and diagnostics sectors. Prior to joining Aquilo, John’s advisory transaction experience includes Medivation’s collaboration with Pfizer, Myriad Genetics’ spin-off of its pharmaceutical business and Agensys’ sale to Astellas. John also led financings for Seattle Genetics, Genomic Health, Array BioPharma, Myriad Genetics and MannKind.
John received a Masters in International Business Administration from the Moore School of Business at the University of South Carolina, where he graduated Beta Gamma Sigma, and a BA from the University of Virginia.
In July 2012, John opened Aquilo’s office in Cambridge, MA.
Contact
Phone: (617) 401-2483
Bio
Kelly joined Aquilo Partners in May 2017. Prior to Aquilo, she worked as a senior associate consultant at Trinity Partners, a life sciences consulting firm based in Waltham, MA. Kelly received a BA in Molecular Biology in 2015 from Princeton University, where she also was a member of the Women’s Varsity Water Polo team.
Contact
Phone: (415) 677-8939
Bio
Mateen joined Aquilo Partners in March 2021. Prior to Aquilo, he interned at Credit Suisse in the Equity Capital Markets group. Mateen received his BA in Mathematics in 2020 from Amherst College, where he was also a member of the Men’s Varsity Squash team.
Contact
Phone: (415) 677-9773
Bio
Sofia joined Aquilo Partners in October 2023. Prior to Aquilo, she worked as an associate consultant at Trinity Life Sciences, a life sciences consulting firm. Sofia received a BS in Molecular, Cellular, and Developmental Biology in 2021 from Yale University, where she also conducted research characterizing the role of the TUG C-terminus product in the regulation of energy expenditure.
Contact
Phone: (617) 875-0032